share_log

4: Statement of changes in beneficial ownership of securities-Director Farley Chele Chiavacci

4: Statement of changes in beneficial ownership of securities-Director Farley Chele Chiavacci

4:持股变动声明-董事 Farley Chele Chiavacci
美股SEC公告 ·  12/21 06:10

Moomoo AI 已提取核心信息

Farley Chele Chiavacci, associated with Conduit Pharmaceuticals, has reported a transaction scheduled for 12/18/2024. The reporting person's address is listed as 4851 Tamiami Trail North, Suite 200, Naples, FL, 34103.While the announcement provides the date of the earliest transaction, it does not disclose the nature, volume, or value of the securities involved. The relationship between the reporting person and the issuer is not specified in the provided information.It's important to note that this report is for a future transaction, as the date provided (12/18/2024) has not yet occurred. Investors should be aware that the lack of detailed transaction information limits the ability to assess the potential impact on the company's stock.
Farley Chele Chiavacci, associated with Conduit Pharmaceuticals, has reported a transaction scheduled for 12/18/2024. The reporting person's address is listed as 4851 Tamiami Trail North, Suite 200, Naples, FL, 34103.While the announcement provides the date of the earliest transaction, it does not disclose the nature, volume, or value of the securities involved. The relationship between the reporting person and the issuer is not specified in the provided information.It's important to note that this report is for a future transaction, as the date provided (12/18/2024) has not yet occurred. Investors should be aware that the lack of detailed transaction information limits the ability to assess the potential impact on the company's stock.
Farley Chele Chiavacci与Conduit Pharmaceuticals有关,已报告定于2024年12月18日进行的一笔交易。报告人的地址列为佛罗里达州那不勒斯市Tamiami Trail North 4851号,200套房,邮政编码34103。虽然公告提供了最早交易的日期,但并未披露涉及的证券的性质、成交量或价值。报告人与发行人之间的关系在提供的信息中并未说明。需要注意的是,该报告是关于未来的交易,因为提供的日期(2024年12月18日)尚未到来。投资者应注意,缺乏详细的交易信息限制了评估可能对公司股票产生影响的能力。
Farley Chele Chiavacci与Conduit Pharmaceuticals有关,已报告定于2024年12月18日进行的一笔交易。报告人的地址列为佛罗里达州那不勒斯市Tamiami Trail North 4851号,200套房,邮政编码34103。虽然公告提供了最早交易的日期,但并未披露涉及的证券的性质、成交量或价值。报告人与发行人之间的关系在提供的信息中并未说明。需要注意的是,该报告是关于未来的交易,因为提供的日期(2024年12月18日)尚未到来。投资者应注意,缺乏详细的交易信息限制了评估可能对公司股票产生影响的能力。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息